EXECUTIVE COMMITTEE

Gilles Legault

Gilles Legault

Past Chair

Gilles Legault is Senior Counsel, Global Legal Affairs at CN in Montreal where he handles the insurance portfolio for CN and its subsidiaries and the legal affairs for CN’s Supply Chain Solutions Group. Prior to joining CN in 2000, he worked for the Ministry of External Trade of the Quebec Government (1986-1990) in Quebec City before joining the Canadian International Trade Tribunal and the Department of Foreign Affairs (1990-2000) in Ottawa.  Gilles is past Chairman of the Chartered Institute of Logistics and Transport in North America (CILTNA) in Ottawa (2008-2011), and currently the Chair of CILTNA’s Quebec Chapter.  In May 2016, Gilles was appointed International Vice-President of the Chartered Institute of Logistics and Transport constituted in the United Kingdom.  He is also a member of the Infrastructures, Transport & Logistics Committee of the Fédération des chambres de commerce du Québec (FCCQ) since 2009, and a representative for the rail industry on the Consensus-Building Forum on Maritime Transport of the Quebec Government.  Gilles was appointed on the Board of directors of the Collège Jean de la Mennais in Laprairie in November 2015.

Within the LLS-LLSC family, Gilles sat on the National Board of Directors of the US Leukemia and Lymphoma Society from 2013 to 2016.  Gilles previously chaired the Leadership Committee of the Light The Night Walk in Montreal.  He was also corporate chair of LTN Walk in 2010. Gilles remains active on the Montreal LTN Walk Volunteer Leadership Committee.

Dillon Cameron

Dillon Cameron

Secretary

Dillon Cameron, CFA, joined Deans Knight Capital Management Ltd. in 2000 and has since become a partner of the firm. He is now responsible for managing the Deans Knight Income Strategy. Dillon is actively involved as a mentor in the UBC PMF program, guiding individuals who are pursuing similar careers.

In May 2009, Dillon completed his first triathlon and also became the top fundraiser in Canada as a member of The Leukemia & Lymphoma Society of Canada (LLSC) Team In Training program. It is through his involvement with Team In Training that Dillon joined the Light The Night (LTN) team to achieve increased support from the corporate community. As corporate Walk chair, Dillon encourages companies in Metro Vancouver to support LLSC’s mission by registering a corporate team and sponsoring Light The Night with a donation. Dillon was born and raised in Vancouver and lives there with his wife and young twins.

Eli Gembom

Eli Gembom

Treasurer

Eli obtained his CA designation at PricewaterhouseCoopers LLP in Toronto, where he worked in the business advisory and assurance practices. As Principal CA at Segal LLP, Eli's responsibilities include leading audit and advisory engagements. Eli specializes in delivering advisory services such as financial forecasts, cash-flow budgeting, profit improvement and transaction support. In addition, Eli plays a very active role in the firm's marketing and business development. He has experience with the preparation of business plans, financial packages and budgets reports to assist with client financing and restructuring.

Ted Moroz

Ted Moroz

Chair of the Board

Ted Moroz has been President of The Beer Store and Brewers' Distributor Limited since September, 2009. In this role he oversees 450 Retail Stores in Ontario, 16 Distribution Centres from British Columbia to Ottawa, and multiple cross-dock facilities throughout Canada, with a total of 7,000+ employees. Ted started his career with The Beer Store (then Brewers Retail Inc.) in 1989, holding various management positions over the years. The Beer Store has been a proud partner of United Food & Commercial Workers (UFCW) Local 12R24 in organizing an annual Returns For Leukemia Bottle Drive since 2006. Ted joined the LLSC National Board in 2010. 

James  Beck

James Beck

Director

Jim Beck is a Certified Financial Planning Practitioner, major shareholder and principal of Hefren-Tillotson, a Pittsburgh-based financial planning/investment firm.  He has over 25 years of experience in investments and financial planning. Jim’s indirect involvement with Leukemia & Lymphoma Society of Canada dates back to 1951 when his 4-year-old brother lost his battle with leukemia.  He has been active in his local chapter in numerous capacities over the past 25 years, including chapter president and treasurer.  Jim joined the National Board in 2008, and serves on the donor development, investment and advancement committees.

Scott Carroll

Scott Carroll

Vice Chair

Scott A. Carroll is the resident manager of the Cincinnati, Ohio office of Jackson Lewis LLP.  Scott has represented clients across the spectrum of labor and employment law, including wrongful discharge litigation, collective bargaining,union avoidance, and human resources counseling.  He has expertise in drafting,counseling, prosecuting, and defending theft of trade secret cases and/or non-compete, non-solicitation cases.  Scott is a member of the U.S. Sixth Circuit Bar Association, the Federal Bar Association, the Ohio State Bar Association, and the Cincinnati Bar Association.  He received his B.S. degree from the University of Cincinnati in 1990, and he earned his J.D. from the University of Cincinnati -College of Law in 1993, where he was a member of the University of Cincinnati Law Review.   Scott became a member of the South Ohio chapter in 2002 and was chapter president in 2005.  

Louis J. DeGennaro

Louis J. DeGennaro

Director


Louis J. DeGennaro, Ph.D., was named president and chief executive officer of The Leukemia & Lymphoma Society (LLS) in September 2014 and now leads theoperations of this $300 million cancer patient advocacy agency with headquartersin White Plains, New York.

A critical member of the LLS executive leadership team, he joined LLS in 2005 andwas named chief mission officer in 2009, with responsibility for leadership of LLS’smission functions of research, patient access, education, public policy andadvocacy. Dr. DeGennaro is recognized as the key architect of LLS’s cures andaccess agenda to help save lives of blood cancer patients as well as the LLSTherapy Acceleration Program® - a venture philanthropy endeavor that definedthe role of nonprofit organizations in supporting drug discovery and developmentwith the biotechnology industry.

Dr. DeGennaro has more than 25 years of research, drug development andexecutive management experience in academic and private sector settings. Hereceived his Ph.D. in biochemistry from the University of California at SanFrancisco and did his post-doctoral research at the Yale University School ofMedicine.  His previous academic appointments include research group leader,Max Planck Institute in Munich, Germany and associate professor of neurologyand cell biology, University of Massachusetts Medical School. Dr. DeGennaro's private-sector positions include senior director of molecular genetics at WyethPharmaceuticals, Princeton, NJ, and executive vice president for research anddevelopment, SynX Pharma, Inc. in Toronto, Canada.